Free Trial

Kineta (KA) News Today

→ Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad)
Free KA Stock Alerts
$0.46
-0.01 (-2.13%)
(As of 06/10/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends
May 16, 2024 | morningstar.com
Kineta Inc KA
May 15, 2024 | msn.com
KA Stock Earnings: Kineta Misses EPS for Q1 2024
May 15, 2024 | globenewswire.com
Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial and Corporate Activities
April 18, 2024 | msn.com
Kineta (KA) Price Target Increased by 25.58% to 13.77
April 9, 2024 | finanznachrichten.de
Kineta, Inc.: Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial
April 8, 2024 | globenewswire.com
Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial
March 22, 2024 | finanznachrichten.de
Kineta, Inc.: Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update
March 21, 2024 | globenewswire.com
Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update
March 12, 2024 | globenewswire.com
KVA12123 Clears Additional Cohorts in Monotherapy and in Combination Therapy Arms in the Phase 1/2 VISTA-101 Clinical Trial; Initial Clinical Response Data Reported
March 1, 2024 | bizjournals.com
Kineta CEO laid off as cutbacks leave biotech with 4 employees
February 29, 2024 | msn.com
Kineta stock falls ~25.7% after co cuts workforce by 64%, including CEO
February 29, 2024 | globenewswire.com
Kineta Announces Restructuring and Exploration of Strategic Alternatives
February 22, 2024 | finance.yahoo.com
Kineta to Present New Preclinical Data on its Anti-VISTA Antibody KVA12123 in Acute Myeloid Leukemia at the AACR Blood Cancer Discovery Symposium
February 22, 2024 | globenewswire.com
Kineta to Present New Preclinical Data on its Anti-VISTA Antibody KVA12123 in Acute Myeloid Leukemia at the AACR Blood Cancer Discovery Symposium
February 14, 2024 | finance.yahoo.com
Kineta to Present at Upcoming Investor Conferences
February 14, 2024 | globenewswire.com
Kineta to Present at Upcoming Investor Conferences
February 7, 2024 | stockhouse.com
Kineta to Participate in H.C. Wainwright Virtual @Home Fireside Chat Series
January 29, 2024 | finance.yahoo.com
KA: Phase I/II Update
January 17, 2024 | finanznachrichten.de
Kineta, Inc.: Kineta Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors
December 13, 2023 | finance.yahoo.com
Kineta Publishes Preclinical Data Demonstrating the Potential of Anti-VISTA Antibody KVA12123 as an Immunomodulatory Therapy for Cancer
December 12, 2023 | finance.yahoo.com
Kineta to Present at the Life Sciences Investor Forum December 14th
November 28, 2023 | finance.yahoo.com
Kineta to Host KOL Event to Review New Data from VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors on December 5, 2023
November 9, 2023 | finance.yahoo.com
Kineta to Present at the 5th Annual Macrophage-Directed Therapies Summit
November 8, 2023 | markets.businessinsider.com
Buy Rating for Kineta Backed by Promising Drug Trials and Solid Financial Performance
November 7, 2023 | msn.com
KA: Third Quarter Results - MSN
November 7, 2023 | finance.yahoo.com
KA: Third Quarter Results
November 6, 2023 | benzinga.com
Kineta Unveils Positive New Data from VISTA-101 Clinical Trial of KVA12123 at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting
November 6, 2023 | finance.yahoo.com
Kineta Unveils Positive New Data from VISTA-101 Clinical Trial of KVA12123 at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
November 4, 2023 | finance.yahoo.com
Kineta Insider Purchases Yet To Pay Off Regardless Of Recent Strength
November 4, 2023 | finanznachrichten.de
Kineta, Inc.: Kineta Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 3, 2023 | benzinga.com
Kineta Presents New Preclinical Data on Lead Anti-CD27 Monoclonal Antibody at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting
November 3, 2023 | chron.com
Kineta: Q3 Earnings Snapshot
November 3, 2023 | finance.yahoo.com
Kineta Presents New Preclinical Data on Lead Anti-CD27 Monoclonal Antibody at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
November 3, 2023 | finance.yahoo.com
Kineta Reports Third Quarter 2023 Financial Results and Provides Corporate Update
October 18, 2023 | markets.businessinsider.com
Promising Prospects for Kineta’s VISTA-101 Trial and KVA12123 Monotherapy Drive Buy Rating
October 17, 2023 | finance.yahoo.com
Kineta Announces First Patient Dosed in Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors
October 12, 2023 | finance.yahoo.com
KA: Autumn Activity
October 12, 2023 | finance.yahoo.com
Kineta Announces KVA12123 and Anti-CD27 Agonist Antibody Abstracts Accepted for Poster Presentations at Society for Immunotherapy of Cancer (SITC) 2023
October 12, 2023 | marketbeat.com
Trading was temporarily halted for "KA" at 10:10 AM with a stated reason of "LULD pause."
October 9, 2023 | finance.yahoo.com
Kineta to Present Preclinical Data on VISTA Blocking KVA12123 at Immuno US 2023
October 5, 2023 | finance.yahoo.com
Kineta, Inc. Announces Closing of $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
October 4, 2023 | finance.yahoo.com
Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
October 4, 2023 | finance.yahoo.com
Kineta Presents New Preclinical Data on Lead Anti-CD27 Agonist Antibody at AACR Special Conference on Tumor Immunology and Immunotherapy
September 28, 2023 | finance.yahoo.com
Kineta Announces Participation at October Investor Conferences
September 25, 2023 | finance.yahoo.com
Kineta to Present New Preclinical Data on Lead Anti-CD27 Agonist Antibody at AACR Special Conference on Tumor Immunology and Immunotherapy
September 18, 2023 | finance.yahoo.com
Kineta Announces New Research Agreement to Evaluate VISTA Biomarker Expression
September 16, 2023 | finance.yahoo.com
Insider Buying: Thierry Guillaudeux Acquires 10,000 Shares of Kineta Inc
August 31, 2023 | finance.yahoo.com
Kineta to Participate in Upcoming Investor Conferences
August 16, 2023 | finance.yahoo.com
KA: Second Quarter Results
August 15, 2023 | finance.yahoo.com
Kineta Second Quarter 2023 Earnings: Beats Expectations
Get Kineta News Delivered to You Automatically

Sign up to receive the latest news and ratings for KA and its competitors with MarketBeat's FREE daily newsletter.

DON’T buy gold until you read this (Ad)

If you're an American who understands that your money is rotting away as you read this email… Then this is for YOU. 99% of people are buying gold the wrong way.

Reserve your seat here.

KA Media Mentions By Week

KA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KA
News Sentiment
▼
0.00

0.76
▲
Average
Medical
News Sentiment

KA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KA Articles
This Week
▼
0

1
▲
KA Articles
Average Week

Get Kineta News Delivered to You Automatically

Sign up to receive the latest news and ratings for KA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:KA) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners
Moonshot Coins for the Current Crypto Run
Did you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...
Crypto 101 Media | Sponsored
Bill Clinton Backing Biden Replacement???
Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...
The Freeport Society | Sponsored
DON’T buy gold until you read this
If you're an American who understands that your money is rotting away as you read this email… Then this is ...
Sasco Gold LLC | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
Hurry! Buy this stock before the Robinhood traders do!
Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...
Traders Agency | Sponsored
The Only Energy Play You Should Be Looking At
Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...
Wealthpin Pro | Sponsored